{{Rsnum
|rsid=12954803
|Chromosome=18
|position=24556605
|Orientation=plus
|GMAF=0.0978
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 70.8 | 25.7 | 3.5
| HCB | 98.5 | 1.5 | 0.0
| JPT | 94.7 | 5.3 | 0.0
| YRI | 89.1 | 10.9 | 0.0
| ASW | 86.0 | 14.0 | 0.0
| CHB | 98.5 | 1.5 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 51.5 | 43.6 | 5.0
| LWK | 83.6 | 16.4 | 0.0
| MEX | 79.3 | 20.7 | 0.0
| MKK | 91.7 | 8.3 | 0.0
| TSI | 60.8 | 35.3 | 3.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (docetaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=8E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}